We've found
15,419
archived clinical trials in
Pulmonary
We've found
15,419
archived clinical trials in
Pulmonary
Precision of IMED-4 Lung Fluid Measurements
Updated: 10/13/2015
Precision of IMED-4 Lung Fluid Measurements
Status: Enrolling
Updated: 10/13/2015
Precision of IMED-4 Lung Fluid Measurements
Updated: 10/13/2015
Precision of IMED-4 Lung Fluid Measurements
Status: Enrolling
Updated: 10/13/2015
Click here to add this to my saved trials
Precision of IMED-4 Lung Fluid Measurements
Updated: 10/13/2015
Precision of IMED-4 Lung Fluid Measurements
Status: Enrolling
Updated: 10/13/2015
Precision of IMED-4 Lung Fluid Measurements
Updated: 10/13/2015
Precision of IMED-4 Lung Fluid Measurements
Status: Enrolling
Updated: 10/13/2015
Click here to add this to my saved trials
Precision of IMED-4 Lung Fluid Measurements
Updated: 10/13/2015
Precision of IMED-4 Lung Fluid Measurements
Status: Enrolling
Updated: 10/13/2015
Precision of IMED-4 Lung Fluid Measurements
Updated: 10/13/2015
Precision of IMED-4 Lung Fluid Measurements
Status: Enrolling
Updated: 10/13/2015
Click here to add this to my saved trials
Pulmonary Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation
Updated: 10/13/2015
Pulmonary Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation.
Status: Enrolling
Updated: 10/13/2015
Pulmonary Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation
Updated: 10/13/2015
Pulmonary Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation.
Status: Enrolling
Updated: 10/13/2015
Click here to add this to my saved trials
RSV F Dose-Ranging Study in Women
Updated: 10/15/2015
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated: 10/15/2015
RSV F Dose-Ranging Study in Women
Updated: 10/15/2015
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated: 10/15/2015
Click here to add this to my saved trials
RSV F Dose-Ranging Study in Women
Updated: 10/15/2015
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated: 10/15/2015
RSV F Dose-Ranging Study in Women
Updated: 10/15/2015
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated: 10/15/2015
Click here to add this to my saved trials
RSV F Dose-Ranging Study in Women
Updated: 10/15/2015
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated: 10/15/2015
RSV F Dose-Ranging Study in Women
Updated: 10/15/2015
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated: 10/15/2015
Click here to add this to my saved trials
RSV F Dose-Ranging Study in Women
Updated: 10/15/2015
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated: 10/15/2015
RSV F Dose-Ranging Study in Women
Updated: 10/15/2015
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated: 10/15/2015
Click here to add this to my saved trials
RSV F Dose-Ranging Study in Women
Updated: 10/15/2015
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated: 10/15/2015
RSV F Dose-Ranging Study in Women
Updated: 10/15/2015
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated: 10/15/2015
Click here to add this to my saved trials
RSV F Dose-Ranging Study in Women
Updated: 10/15/2015
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated: 10/15/2015
RSV F Dose-Ranging Study in Women
Updated: 10/15/2015
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated: 10/15/2015
Click here to add this to my saved trials
RSV F Dose-Ranging Study in Women
Updated: 10/15/2015
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated: 10/15/2015
RSV F Dose-Ranging Study in Women
Updated: 10/15/2015
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated: 10/15/2015
Click here to add this to my saved trials
RSV F Dose-Ranging Study in Women
Updated: 10/15/2015
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated: 10/15/2015
RSV F Dose-Ranging Study in Women
Updated: 10/15/2015
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated: 10/15/2015
Click here to add this to my saved trials
RSV F Dose-Ranging Study in Women
Updated: 10/15/2015
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated: 10/15/2015
RSV F Dose-Ranging Study in Women
Updated: 10/15/2015
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated: 10/15/2015
Click here to add this to my saved trials
RSV F Dose-Ranging Study in Women
Updated: 10/15/2015
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated: 10/15/2015
RSV F Dose-Ranging Study in Women
Updated: 10/15/2015
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Multiple Formulations of an RSV F Particle Vaccine With Aluminum, in Healthy Women of Child-Bearing Age
Status: Enrolling
Updated: 10/15/2015
Click here to add this to my saved trials
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
Updated: 10/16/2015
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/16/2015
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
Updated: 10/16/2015
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/16/2015
Click here to add this to my saved trials
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
Updated: 10/16/2015
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/16/2015
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
Updated: 10/16/2015
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/16/2015
Click here to add this to my saved trials
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
Updated: 10/16/2015
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/16/2015
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
Updated: 10/16/2015
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/16/2015
Click here to add this to my saved trials
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
Updated: 10/16/2015
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/16/2015
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
Updated: 10/16/2015
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/16/2015
Click here to add this to my saved trials
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
Updated: 10/16/2015
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/16/2015
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
Updated: 10/16/2015
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/16/2015
Click here to add this to my saved trials
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
Updated: 10/16/2015
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/16/2015
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
Updated: 10/16/2015
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/16/2015
Click here to add this to my saved trials
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
Updated: 10/16/2015
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/16/2015
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
Updated: 10/16/2015
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/16/2015
Click here to add this to my saved trials
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
Updated: 10/16/2015
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/16/2015
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
Updated: 10/16/2015
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/16/2015
Click here to add this to my saved trials
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
Updated: 10/16/2015
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/16/2015
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
Updated: 10/16/2015
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/16/2015
Click here to add this to my saved trials
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
Updated: 10/16/2015
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/16/2015
Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)
Updated: 10/16/2015
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/16/2015
Click here to add this to my saved trials
Outlook Quality of Life Intervention Study
Updated: 10/19/2015
Outlook: An Intervention to Improve Quality of Life in Serious Illness Study
Status: Enrolling
Updated: 10/19/2015
Outlook Quality of Life Intervention Study
Updated: 10/19/2015
Outlook: An Intervention to Improve Quality of Life in Serious Illness Study
Status: Enrolling
Updated: 10/19/2015
Click here to add this to my saved trials
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Updated: 10/19/2015
Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)
Status: Enrolling
Updated: 10/19/2015
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Updated: 10/19/2015
Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)
Status: Enrolling
Updated: 10/19/2015
Click here to add this to my saved trials
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Updated: 10/19/2015
Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)
Status: Enrolling
Updated: 10/19/2015
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Updated: 10/19/2015
Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)
Status: Enrolling
Updated: 10/19/2015
Click here to add this to my saved trials
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Updated: 10/19/2015
Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)
Status: Enrolling
Updated: 10/19/2015
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Updated: 10/19/2015
Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)
Status: Enrolling
Updated: 10/19/2015
Click here to add this to my saved trials
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Updated: 10/19/2015
Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)
Status: Enrolling
Updated: 10/19/2015
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Updated: 10/19/2015
Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)
Status: Enrolling
Updated: 10/19/2015
Click here to add this to my saved trials
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Updated: 10/19/2015
Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)
Status: Enrolling
Updated: 10/19/2015
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Updated: 10/19/2015
Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)
Status: Enrolling
Updated: 10/19/2015
Click here to add this to my saved trials
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Updated: 10/19/2015
Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)
Status: Enrolling
Updated: 10/19/2015
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Updated: 10/19/2015
Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)
Status: Enrolling
Updated: 10/19/2015
Click here to add this to my saved trials
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Updated: 10/19/2015
Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)
Status: Enrolling
Updated: 10/19/2015
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Updated: 10/19/2015
Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)
Status: Enrolling
Updated: 10/19/2015
Click here to add this to my saved trials
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Updated: 10/19/2015
Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)
Status: Enrolling
Updated: 10/19/2015
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Updated: 10/19/2015
Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)
Status: Enrolling
Updated: 10/19/2015
Click here to add this to my saved trials
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Updated: 10/19/2015
Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)
Status: Enrolling
Updated: 10/19/2015
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Updated: 10/19/2015
Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)
Status: Enrolling
Updated: 10/19/2015
Click here to add this to my saved trials
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Updated: 10/19/2015
Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)
Status: Enrolling
Updated: 10/19/2015
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Updated: 10/19/2015
Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)
Status: Enrolling
Updated: 10/19/2015
Click here to add this to my saved trials
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Updated: 10/19/2015
Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)
Status: Enrolling
Updated: 10/19/2015
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Updated: 10/19/2015
Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)
Status: Enrolling
Updated: 10/19/2015
Click here to add this to my saved trials
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Updated: 10/19/2015
Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)
Status: Enrolling
Updated: 10/19/2015
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Updated: 10/19/2015
Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)
Status: Enrolling
Updated: 10/19/2015
Click here to add this to my saved trials
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Updated: 10/19/2015
Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)
Status: Enrolling
Updated: 10/19/2015
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Updated: 10/19/2015
Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)
Status: Enrolling
Updated: 10/19/2015
Click here to add this to my saved trials
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Updated: 10/19/2015
Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)
Status: Enrolling
Updated: 10/19/2015
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Updated: 10/19/2015
Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)
Status: Enrolling
Updated: 10/19/2015
Click here to add this to my saved trials
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Updated: 10/19/2015
Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)
Status: Enrolling
Updated: 10/19/2015
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Updated: 10/19/2015
Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)
Status: Enrolling
Updated: 10/19/2015
Click here to add this to my saved trials
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Updated: 10/19/2015
Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)
Status: Enrolling
Updated: 10/19/2015
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Updated: 10/19/2015
Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)
Status: Enrolling
Updated: 10/19/2015
Click here to add this to my saved trials
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Updated: 10/19/2015
Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)
Status: Enrolling
Updated: 10/19/2015
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Updated: 10/19/2015
Randomized Clinical Trial of the Beneficial Effects of Antenatal Magnesium Sulfate (BEAM)
Status: Enrolling
Updated: 10/19/2015
Click here to add this to my saved trials
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
Updated: 10/19/2015
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/19/2015
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
Updated: 10/19/2015
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/19/2015
Click here to add this to my saved trials
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
Updated: 10/19/2015
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/19/2015
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
Updated: 10/19/2015
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/19/2015
Click here to add this to my saved trials
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
Updated: 10/19/2015
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/19/2015
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
Updated: 10/19/2015
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/19/2015
Click here to add this to my saved trials
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
Updated: 10/19/2015
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/19/2015
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
Updated: 10/19/2015
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/19/2015
Click here to add this to my saved trials
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
Updated: 10/19/2015
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/19/2015
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
Updated: 10/19/2015
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/19/2015
Click here to add this to my saved trials
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
Updated: 10/19/2015
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/19/2015
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
Updated: 10/19/2015
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/19/2015
Click here to add this to my saved trials
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
Updated: 10/19/2015
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/19/2015
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
Updated: 10/19/2015
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/19/2015
Click here to add this to my saved trials
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
Updated: 10/19/2015
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/19/2015
SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)
Updated: 10/19/2015
A Phase 2b, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SUN11031 for Injection Administered Subcutaneously Twice Daily for 12 Weeks to Subjects Having Cachexia Associated With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 10/19/2015
Click here to add this to my saved trials